Drug Trial Radar · NCT07300943
Study in Advanced Solid Tumor Patients
Last checked: Nov 19, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
306
Planned (sponsor's estimate)
Start
Mar 19, 2026
Primary completion
Dec 31, 2027
Study completion Jul 17, 2028
Sponsor
- Lead sponsor
- Callio TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will be conducted in 2 phases: Phase 1: Dose-escalation and Dose Level Expansion, Phase 1 will determine the maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE). Phase 2: Tumor-Specific Expansions with Dose Optimization, Phase 2 will further evaluate CLIO-8221 in tumor-specific expansion cohorts to optimize dosing and assess preliminary efficacy.
Conditions
- Advanced Solid Tumor
Interventions
CLIO-8221Drug
intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Type, incidence, severity, and seriousness of adverse events (AEs)Time frame: Through end of treatment, up to approximately 2 years.
- Type, incidence, and severity of laboratory abnormalitiesTime frame: Through end of treatment, up to approximately 2 years.
- Incidence of dose limiting toxicities dose (RP2D) of CLIO-8221Time frame: From first dose through study day 21.
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
DFCI
Boston, Massachusetts · Not yet recruiting
Sarah Cannon Research Institute 335 24th Avenue North, Suite 400
Nashville, Tennessee · Recruiting
MD Anderson Cancer Center
Houston, Texas · Recruiting
START San Antonio
San Antonio, Texas · Recruiting
START Mountain
West Valley City, Utah · Recruiting
Scientia Clinical Research
Randwick, New South Wales, Australia · Recruiting
Integrated Clinical Oncology Network Pty Ltd
South Brisbane, Queensland, Australia · Recruiting
Peter Maccallum Cancer Centre
Box Hill, Victoria, Australia · Recruiting
AlfredHealth
Heidelberg, Victoria, Australia · Recruiting
Royal Melbourne Hospital
Melbourne, Victoria, Australia · Recruiting
Linear Clinical Research Ltd
Nedlands, Western Australia, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.